{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-022547","form_type":"8-K","ticker":"SRRK","cik":"0001727196","company_name":"Scholar Rock Holding Corp","filed_at":"2026-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.015683+00:00","generated_at":"2026-05-15T22:18:23.920988+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Scholar Rock reports FY2025 net loss $378M; BLA resubmission expected in 2026 after FDA reinspection","bullets":["Net loss $377.9M for 2025 ($3.29 per share) vs $246.3M in 2024; no revenue; cash $367.6M at Dec 31.","Apitegromab BLA resubmission planned for 2026 after successful FDA reinspection of Catalent Indiana facility.","Secured up to $550M non-dilutive debt facility with Blue Owl Capital; $100M drawn to retire prior debt.","EMA decision on apitegromab MAA expected mid-2026; European launch (starting Germany) in H2 2026.","Phase 2 FORGE trial for FSHD on track for mid-2026; SRK-439 Phase 1 topline data expected H2 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-022547","json":"https://secwatch.observer/filing/0001104659-26-022547.json","markdown":"https://secwatch.observer/filing/0001104659-26-022547.md","text":"https://secwatch.observer/filing/0001104659-26-022547.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1727196/000110465926022547/0001104659-26-022547-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1727196/000110465926022547/srrk-20260303x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T22:18:23.920988+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}